Surmodics, Inc.
NASDAQ: SRDX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Gary R. Maharaj
- Employees
- 389
- Headquarters
- Eden Prairie, United States
- IPO year
- 1998
- Market cap
- $614.5M
- Website
- https://www.surmodics.com
Loading SRDX…
Loading profile data…Frequently asked questions about SRDX
What does Surmodics, Inc. (SRDX) do?
Surmodics, Inc., together with its affiliates, specializes in providing advanced surface modification solutions tailored for intravascular medical devices. Additionally, the company supplies specialized chemical components essential for in vitro diagnostic immunoassay tests and microarrays. Its operations span both the United States and internat...
Where does SRDX trade?
Surmodics, Inc. (SRDX) trades on the NASDAQ Global Select.
What sector is SRDX in?
Surmodics, Inc. (SRDX) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Surmodics, Inc.?
Gary R. Maharaj is the chief executive officer of Surmodics, Inc. (SRDX).
Where is Surmodics, Inc. headquartered?
Surmodics, Inc. is headquartered in United States.
Does SRDX pay a dividend?
Surmodics, Inc. (SRDX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did SRDX go public?
Surmodics, Inc. (SRDX) completed its initial public offering in 1998.